Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


Articles published in J Clin Invest

Retrieve available abstracts of 17 articles:
HTML format



Single Articles


    May 2022
  1. GLINTON KE, Ma W, Lantz C, Grigoryeva LS, et al
    Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation.
    J Clin Invest. 2022;132.
    PubMed     Abstract available


    March 2022
  2. HENRION D
    Modulating the immune response to reduce hypertension-associated cardiovascular damage.
    J Clin Invest. 2022;132.
    PubMed     Abstract available


    February 2022
  3. FAILER T, Amponsah-Offeh M, Neuwirth A, Kourtzelis I, et al
    Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation.
    J Clin Invest. 2022 Feb 8. pii: 126155. doi: 10.1172/JCI126155.
    PubMed     Abstract available


  4. HUMERES C, Shinde AV, Hanna A, Alex L, et al
    Smad7 effects on TGF-beta and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure.
    J Clin Invest. 2022;132.
    PubMed     Abstract available


    January 2022
  5. BAILEY LR, Davis J
    If these myocytes could talk, they would speak the language of metabolites.
    J Clin Invest. 2022;132.
    PubMed     Abstract available


  6. MUSUNURU K
    Moving toward genome-editing therapies for cardiovascular diseases.
    J Clin Invest. 2022;132.
    PubMed     Abstract available


    November 2021
  7. JIANG K, Tu Z, Chen K, Xu Y, et al
    Gasdermin D inhibition confers antineutrophil mediated cardioprotection in acute myocardial infarction.
    J Clin Invest. 2021 Nov 9. pii: 151268. doi: 10.1172/JCI151268.
    PubMed     Abstract available


    October 2021
  8. BRAKENHIELM E, Chen Y, Cao Y
    Lymphatics in the broken heart.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


    September 2021
  9. KNUTSON AK, Williams AL, Boisvert WA, Shohet RV, et al
    HIF in the heart: development, metabolism, ischemia, and atherosclerosis.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


    August 2021
  10. KELLER IV TCS, Lim L, Shewale SV, McDaid K, et al
    Genetic blockade of lymphangiogenesis does not impair cardiac function after myocardial infarction.
    J Clin Invest. 2021 Aug 17. pii: e147070. doi: 10.1172/JCI147070.
    PubMed     Abstract available


    July 2021
  11. LIU M, Liu H, Parthiban P, Kang GJ, et al
    Inhibition of the unfolded protein response reduces arrhythmic risk after myocardial infarction.
    J Clin Invest. 2021 Jul 29. pii: e147836. doi: 10.1172/JCI147836.
    PubMed     Abstract available


  12. PRABHU SD
    Healing and repair after myocardial infarction: the forgotten but resurgent basophil.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


  13. SICKLINGER F, Meyer IS, Li X, Radtke D, et al
    Basophils balance healing after myocardial infarction via IL-4/IL-13.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


    April 2021
  14. KASIKARA C, Schilperoort M, Gerlach B, Xue C, et al
    Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


    February 2021
  15. DEBERGE M, Glinton K, Subramanian M, Wilsbacher LD, et al
    Macrophage AXL receptor tyrosine kinase inflames the heart after reperfused myocardial infarction.
    J Clin Invest. 2021 Feb 2. pii: 139576. doi: 10.1172/JCI139576.
    PubMed     Abstract available


    January 2021
  16. CALIFF RM, Curtis LH, Harrington RA, Hernandez AF, et al
    Generating evidence for therapeutic effects: the need for well-conducted randomized trials.
    J Clin Invest. 2021;131.
    PubMed    


    March 2020
  17. SIRAJ MA, Mundil D, Beca S, Momen A, et al
    Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-alpha.
    J Clin Invest. 2020;130:1392-1404.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: